PROFESSIONAL EDITION

The largest community of pharma leaders

Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna announces first participant dosed in Phase 1/2 study of Moderna COVID-19 Vaccine in Japan led by Takeda.

Source Business Wire Health: Pharmaceutical NewsRead More

Recent Articles